ValiRx plc

ValiRx plc listed on AIM in October 2006.  ValiRx is creating a portfolio of innovative products through investment in specific development projects.  ValiRx actively manages projects within this portfolio as a trading company and is not an investment vehicle.

The ValiRx business model spreads the risks of life science technology developments by minimising financial exposure and running a set of projects to defined commercial endpoints.  This maximises returns to shareholders by adding value at the earlier stages where value increases per investment unit are the greatest.